Exsegen Genomics
Exsegen Genomics is a genomics company focused on revolutionizing brain tumor diagnosis and management through innovative research and cutting-edge technologies. Their key products include NGS-based tissue biopsy tests and AI/ML-driven liquid biopsy diagnostics that replace invasive surgical biopsies with blood tests. Powered by the world's largest brain tumor bio-repository with nearly 4000 samples, Exsegen leverages comprehensive patented neuro-oncology panels and proprietary algorithms to improve diagnostic accuracy and treatment safety. The company collaborates with over 70 neurosurgeons across 20+ hospitals in India, aiming to provide risk-free, precise diagnostic solutions globally and improve brain cancer patient outcomes.
Exsegen Genomics
Exsegen Genomics is a genomics company focused on revolutionizing brain tumor diagnosis and management through innovative research and cutting-edge technologies. Their key products include NGS-based tissue biopsy tests and AI/ML-driven liquid biopsy diagnostics that replace invasive surgical biopsies with blood tests. Powered by the world's largest brain tumor bio-repository with nearly 4000 samples, Exsegen leverages comprehensive patented neuro-oncology panels and proprietary algorithms to improve diagnostic accuracy and treatment safety. The company collaborates with over 70 neurosurgeons across 20+ hospitals in India, aiming to provide risk-free, precise diagnostic solutions globally and improve brain cancer patient outcomes.